Technical Validation of a Hepatitis C Virus Whole Genome Sequencing Assay for Detection of Genotype and Antiviral Resistance in the Clinical Pathway

Choice of direct acting antiviral (DAA) therapy for Hepatitis C Virus (HCV) in the United Kingdom and similar settings usually requires knowledge of the genotype and, in some cases, antiviral resistance (AVR) profile of the infecting virus. To determine these, most laboratories currently use Sanger...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Microbiol
Hlavní autoři: Manso, Carmen F., Bibby, David F., Lythgow, Kieren, Mohamed, Hodan, Myers, Richard, Williams, David, Piorkowska, Renata, Chan, Yuen T., Bowden, Rory, Ansari, M. Azim, Ip, Camilla L. C., Barnes, Eleanor, Bradshaw, Daniel, Mbisa, Jean L.
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2020
Témata:
Microbiology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7583327/
https://ncbi.nlm.nih.gov/pubmed/33162957
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2020.576572
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky